Gefapixant Citrate (CAS No: 2310299-91-1) is a key pharmaceutical intermediate used in the synthesis of APIs Gefapixant citrate. This compound serves as an essential raw material in API development and synthesis. Explore detailed chemical properties, molecular data, structure information, and verified global suppliers, manufacturers, and distributors of this API intermediate on apicule.
Alternate Names: Lyfnua (TN), Benzenesulfonamide, 5-((2,4-diamino-5-pyrimidinyl)oxy)-2-methoxy-4-(1-methylethyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
CAS No: 2310299-91-1
PubChem CID: 145720531
Mol Formula: C20H27N5O11S
Mol Weight: 545.5 g/mol
Used in API: Gefapixant citrate
IUPAC Name: 5-(2,4-diaminopyrimidin-5-yl)oxy-2-methoxy-4-propan-2-ylbenzenesulfonamide;2-hydroxypropane-1,2,3-tricarboxylic acid
API Intermediate Description: Gefapixant citrate is a selective P2X3 receptor antagonist used for the treatment of chronic cough. By blocking P2X3 receptors on sensory nerves in the airways, it helps reduce the hypersensitive cough reflex associated with refractory or unexplained chronic cough.
